Vaccines, Volume 12, Issue 10
2024 October - 114 articles
Cover Story: HSV vaccine development has been impeded by an absence of predictive animal models and defined correlates of immune protection. We developed a mouse model of repeated sublethal HSV-1 or HSV-2 infection that recapitulates the immune response observed in humans. Primary acute infection elicited neutralizing antibodies but little or no antibody-dependent cell-mediated cytotoxicity (ADCC) activity. Repeated monthly exposures led to the generation of ADCC and an expanded antigenic repertoire without boosting neutralizing titers. Immune serum isolated from mice after repeated but not primary infection passively protected naïve mice; protection was lost if the serum was transferred into mice impaired in ADCC killing. Together, the results highlight the importance of ADCC in protection and provide a new model for testing therapeutic vaccines. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.